Patients’ and healthcare providers’ views regarding dose reduction of tyrosine kinase inhibitors in chronic myeloid leukemia: a qualitative study

Lokhorst DN et al. Oncologist, April 2026 – open access publication

• Share
• Tweet
• Share
• Share